Yun Hee Kang

Yun Hee Kang

Auto-generated profile, based on publicly available information

Yun Hee Kang

Eulji Biomedical Science Research Institute, Eulji University School of Medicine, Daejeon 34824, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2007 in Blood
Verified
Journal Article
Closed access
PDF file
MKMin H H. Kang
Min H H. Kang
YKYun Hee Kang
Yun Hee Kang
BSBarbara Szymanska
Barbara Szymanska
UWUrszula Wilczynska-Kalak
Urszula Wilczynska-Kalak
MSMichael A. Sheard
Michael A. Sheard
CRC. Patrick Reynolds
C. Patrick Reynolds
Defects in apoptosis signaling contribute to poor outcome in pediatric acute lymphoblastic leukemia (ALL), and overexpression of antiapoptotic Bcl-2 (Bcl-2 and Bcl-XL) family proteins has been observed in ALL. ABT-737 is a small-molecule BH3-mimetic that inhibits the antiapoptotic Bcl-2 family proteins. We evaluated the cytotoxicity of ABT-737 in combination with vincristine, dexamethasone, and L-asparaginase (VXL) in 7 ALL cell lines. Multilog synergistic cytotoxicity was observed in all 7 cell lines with ABT-737 plus L-asparaginase or vincristine, and in 5 of 7 cell lines with ABT-737 plus dexamethasone or VXL. In leukemia cells, but not in normal lymphocytes, ABT-737 plus L-asparaginase induced greater mitochondrial depolarization (JC-1 staining); mitochondrial cytochrome c release; activation of Bax, Bid, and caspases (immunoblotting); and eventually apoptosis (annexin V staining) than did either drug alone. In mouse xenografts derived from patients with ALL at diagnosis (ALL-7) or at relapse (ALL-19), event-free survival (EFS) was significantly enhanced with ABT-737 plus VXL relative to VXL or ABT-737 alone (P ≤ .02). Thus, ABT-737 synergistically enhanced VXL cytotoxicity in ALL cell lines via a mitochondrial death pathway and enhanced EFS in VXL-treated mice bearing ALL xenografts. Combining VXL with a BH3-mimetic warrants clinical investigation in ALL at relapse and potentially in chemotherapy-resistant ALL subgroups.

16 April 2008 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
MKMin H H. Kang
Min H H. Kang
ZWZesheng Wan
Zesheng Wan
YKYun Hee Kang
Yun Hee Kang
RSRichard Sposto
Richard Sposto
CRC. Patrick Reynolds
C. Patrick Reynolds
ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and xenografts. A relationship between expression of myeloid cell leukemia 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family of proteins, and resistance to ABT-737 has been reported for various cancers. The synthetic cytotoxic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) is known to generate reactive oxygen species (ROS), and ROS have been shown to activate c-Jun kinase (JNK), which in turn phosphorylates and inhibits Mcl-1. Thus, we investigated whether 4-HPR–mediated inactivation of Mcl-1 could act synergistically with ABT-737 to promote leukemia cell death. Cytotoxicity was determined using the fluorescence-based DIMSCAN assay. Synergy was defined as a combination index (CIN) less than 1. The expression of Bcl-2 family messenger RNAs was measured by real-time reverse transcription–polymerase chain reaction, and caspase activity was measured enzymatically. Changes in Bcl-2 family proteins and release of mitochondrial cytochrome c were detected by immunoblotting. ROS, apoptosis, mitochondrial membrane depolarization, and phospho-JNK were measured by flow cytometry. Gene silencing was by small interfering RNA (siRNA). All statistical tests were two-sided. ABT-737 decreased Mcl-1 protein expression in ABT-737–sensitive ALL cell lines but not in ABT-737–resistant lines. Using the antioxidant ascorbic acid and siRNA-mediated knockdown of JNK, we showed that 4-HPR decreased Mcl-1 via ROS generation (that phosphorylates JNK) in ABT-737-resistant cell lines. Combining ABT-737 with 4-HPR enhanced the mitochondrial apoptotic cascade (percentage of cells with depolarized mitochondrial membrane at 6 hours, ABT-737 vs ABT-737 plus 4-HPR: 24.5% vs 45.5%, difference = 20.1%, 95% CI = 18.9% to 13.9%; P < .001) and caused caspase-dependent, synergistic multilog cytotoxicity in all seven ALL cell lines examined (mean CIN = 0.57, 95% CI = 0.37 to 0.87), with minimal cytotoxicity for normal lymphocytes. An increase of Mcl-1 protein in response to ABT-737 is one mechanism of ABT-737 resistance that can be overcome by 4-HPR, resulting in synergistic cytotoxicity of ABT-737 combined with 4-HPR in ALL cell lines.

1 October 2012 in Cellular Signalling
Verified
Journal Article
Closed access
YKYun Hee Kang
Yun Hee Kang
NJNa Young Ji
Na Young Ji
SHSeung Ro Han
Seung Ro Han
CLChung Il Lee
Chung Il Lee
JKJae Wha Kim
Jae Wha Kim
ESEun Young Song
Eun Young Song

1 May 2012 in Cancer Letters
Verified
Journal Article
Closed access
YKYun Hee Kang
Yun Hee Kang
MPMi-Young Park
Mi-Young Park
DYDo-Young Yoon
Do-Young Yoon
SHSeung Ro Han
Seung Ro Han
CLChung Il Lee
Chung Il Lee
ESEun Young Song
Eun Young Song

1 January 2013 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KKKwang Soo Kim
Kwang Soo Kim
JKJong-Tae Kim
Jong-Tae Kim
SLSeon-Jin Lee
Seon-Jin Lee
MKMin Ah Kang
Min Ah Kang
ICIn Seong Choe
In Seong Choe
HLHee Gu Lee
Hee Gu Lee

7 September 2010 in Amino Acids
Verified
Journal Article
Closed access
PDF file
YKYun Hee Kang
Yun Hee Kang
NJNa Young Ji
Na Young Ji
CLChung Il Lee
Chung Il Lee
HLHee Gu Lee
Hee Gu Lee
JKJae Wha Kim
Jae Wha Kim
ESEun Young Song
Eun Young Song